Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike–ACE2 InteractionScott E. Guimond, Jeremy E. Turnbull, Joanna Said et al.|ACS Central Science|2022Cited by 112
Pixatimod (PG545), a clinical-stage heparan sulfate mimetic, is a potent inhibitor of the SARS-CoV-2 virusScott E. Guimond, Jeremy E. Turnbull, Courtney J. Mycroft‐West et al.|Unknown|2020Cited by 16
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 By Disrupting The Spike-ACE2 interactionScott E. Guimond, Jeremy E. Turnbull, Courtney J. Mycroft‐West et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 12
Amphiphilic Heparinoids as Potent Antiviral Agents against SARS-CoV-2Mohit Chhabra, Vito Ferro, Nanjudaswamy Vijendra Kumar et al.|Journal of Medicinal Chemistry|2024Cited by 7
Integration of molecular modelling and in vitro studies to inhibit LexA proteolysisZachariah P. Schuurs, Neha S. Gandhi|Frontiers in Cellular and Infection Microbiology|2023Cited by 4